BRIEF-Novogen submits IND application for Cantrixil
August 11, 2016 at 07:47 AM EDT
* Novogen submits Investigational New Drug (IND) Application to the U.S. FDA for Cantrixil(TM) in ovarian cancer
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.